UBS initiated coverage of Leidos with a rating of Neutral and set a new price target of $182.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2025 | $200.00 → $165.00 | Buy → Hold | TD Cowen |
| 12/12/2024 | $228.00 → $153.00 | Buy → Neutral | Goldman |
| 12/2/2024 | $182.00 | Neutral | UBS |
| 1/5/2024 | Equal Weight → Overweight | Barclays | |
| 11/17/2023 | Hold → Buy | Argus | |
| 5/25/2023 | $87.00 → $102.00 | Equal Weight → Overweight | Wells Fargo |
| 3/27/2023 | $120.00 → $95.00 | Buy → Hold | Jefferies |
| 12/8/2022 | $130.00 | Buy | Citigroup |
Gift will support scholarships, technology enhancements, and student engagement RESTON, Va., Dec. 3, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced a $750,000 donation to Hampton University in Hampton, Virginia. The gift will benefit students and faculty across multiple disciplines, including the School of Science, the School of Engineering, the School of Liberal Arts and Education, as well as various technological advancements at the university. "We are proud to join with Hampton University to invest in the future of education and technology," said Leidos CEO Tom Bel
RESTON, Va., Oct. 7, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation leader, today announced the appointment of Leslie Fautsch as the company's new chief human resources officer. In this role, Fautsch will be responsible for supporting 48,000 Leidos employees worldwide and shaping the company's differentiated workforce strategy. "I am thrilled to promote Leslie as our new chief human resources officer," said Leidos CEO Tom Bell. "Leslie and our human resources team's efforts to attract and develop the best of the best people will be crucial as we make Leidos
RESTON, Va., Aug. 12, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 innovation leader, today announced the addition of Curtiss-Wright, a global provider of highly engineered, technologically advanced products and services, to the Leidos Alliance Partner Network (LAPN) as a Technology Partner. "Leidos is pleased to welcome Curtiss-Wright's Defense Solutions Division to the LAPN," said Doug Jones, Leidos' Senior Vice President of Defense Systems. "Curtiss-Wright's expertise in developing advanced, highly engineered products and precision components, combined with Leido
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
TD Cowen downgraded Leidos from Buy to Hold and set a new price target of $165.00 from $200.00 previously
Goldman downgraded Leidos from Buy to Neutral and set a new price target of $153.00 from $228.00 previously
UBS initiated coverage of Leidos with a rating of Neutral and set a new price target of $182.00
RESTON, Va., Jan. 14, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced it has scheduled a conference call for Tuesday, Feb. 11, 2025, at 8 a.m. (ET) to announce its fourth quarter and full year 2024 financial results for the period ending Jan. 3, 2025. The company plans to issue its quarterly earnings press release before the conference call on Feb. 11, 2025. The details for the earnings conference call follow: Date: Feb. 11, 2025 Time: 8 a.m. (ET) The company offers a live and replay audio broadcast of the conference call with corresponding press release, presentation materials, and supplemental information at http://ir.leidos.com. To listen via telephone, please follow this lin
Revenues of $4.2 billion, up 7% year-over-yearNet income of $362 million or $2.68 per diluted shareAdjusted EBITDA (non-GAAP) of $596 million (14.2% margin)Non-GAAP Diluted Earnings per Share of $2.93, up 44% year-over-yearCash Flows from Operations of $656 million; Free Cash Flow (non-GAAP) of $633 millionNet Bookings of $8.1 billion (book-to-bill ratio of 1.9 for the quarter and 1.1 for trailing twelve months)RESTON, Va., Oct. 29, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) today reported financial results for the third quarter of fiscal year 2024. "Continued improvement in operating performance across all segments drove excellent revenue growth, record margins for net income a
RESTON, Va., Oct. 25, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per outstanding share of common stock of Leidos Holdings, Inc., a $0.02 increase compared to the prior quarterly dividend of $0.38 per share. The cash dividend is payable on December 31, 2024, to stockholders of record as of the close of business on December 16, 2024. About Leidos Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
8-K - Leidos Holdings, Inc. (0001336920) (Filer)
144 - Leidos Holdings, Inc. (0001336920) (Subject)
10-Q - Leidos Holdings, Inc. (0001336920) (Filer)
RESTON, Va., Jan. 14, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced it has scheduled a conference call for Tuesday, Feb. 11, 2025, at 8 a.m. (ET) to announce its fourth quarter and full year 2024 financial results for the period ending Jan. 3, 2025. The company plans to issue its quarterly earnings press release before the conference call on Feb. 11, 2025. The details for the earnings conference call follow: Date: Feb. 11, 2025 Time: 8 a.m. (ET) The company offers a live and replay audio broadcast of the conference call with corresponding press release, presentation materials, and supplemental information at http://ir.leidos.com. To listen via telephone, please follow this lin
RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the brand name Leidos QTC Health Services, has been awarded a contract by the Veterans Benefits Administration (VBA) for performing Medical Disability Examination Services in Regions 1-4. "With more than 1 million examination cases delivered in 2024, Leidos QTC Health Services continues to drive innovation and increase program efficiency for the VBA," said Liz Porter, Leidos Health & Civil Sector president. "These veteran disabi
RESTON, Va., Dec. 19, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced a new contract to provide critical engineering and sustainment services for Foreign Military Sales (FMS) customers of the U.S. Air Force's F-16 Fighting Falcon. The contract was awarded by the Air Force Life Cycle Management Center, supporting the F-16 System Program Office. The single award, indefinite delivery, indefinite quantity contract has a maximum value of $987 million and 10-year period of performance. "We leveraged our corporate investments in AI and predictive analytics to provide our cust